TEVA (Teva Pharmaceutical Industries Ltd.) שולי הרווח הגולמי

סמל תאגידי ולוגו של Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Industries (TEVA) competes through scale and cost control while operating under severe pricing pressure from regulators. The gross profit margin on the GURU.Markets chart visualizes production efficiency, where 53.50 captures the current value of the indicator. Stable demand for affordable medications makes the holding's business resilient to macroeconomic shocks and market cycles.

TEVA: שולי רווח גולמי Teva Pharmaceutical Industries 04.07.2022 - 20.11.2026

פילוחים אנליטיים ודוחות נתונים של חברת Teva Pharmaceuticals (TEVA)

- שער מניה ותחזית מחירי מומחים:
- פרטי פוזיציית מזומנים ותזרימי מזומנים:
הערכת שווי פונדמנטלית:tevapharm.com (TEVA)
מוצרים מיוצרים של Teva

As a price-taker in the generics market, Teva Pharmaceutical Industries (TEVA) depends on external pricing conditions despite its colossal production volumes. Gross margin measures the portion of revenue remaining after covering direct production costs, reflecting the efficiency of cost-of-goods-sold management. For the investor, this indicator serves as a quality-of-growth filter, identifying the risk of profit erosion amid rising competition. The trend of the gross profit-to-revenue ratio on this chart allows for a real-time assessment of the business model's resilience.